118 related articles for article (PubMed ID: 9723514)
1. Adjusting immunosuppression to the identification of T-cell activating mediators in rejecting transplants: a novel approach to rejection diagnosis and treatment.
Strehlau J; Maslinski W; Chae D; Pavlakis M; Ehrich JH; Strom TB
Transplant Proc; 1998 Aug; 30(5):2389-91. PubMed ID: 9723514
[No Abstract] [Full Text] [Related]
2. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
Makrigiannis AP; Hoskin DW
J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
[TBL] [Abstract][Full Text] [Related]
3. Short-term cytolytic mediators' expression in decidual lymphocytes is enhanced by interleukin-15.
Strbo N; Laskarin G; Bogovic Crncic T; Juretic Frankovic K; Bedenicki I; Sotosek Tokmadzic V; Randic L; Le Bouteiller P; Tabiasco J; Podack ER; Rukavina D
Am J Reprod Immunol; 2006 Mar; 55(3):217-25. PubMed ID: 16451356
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes.
Ye W; Young JD; Liu CC
Cell Immunol; 1996 Nov; 174(1):54-62. PubMed ID: 8929454
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte monitoring in steroid-free immunosuppression.
Strehlau J
Pediatr Transplant; 2003 Feb; 7(1):4-6. PubMed ID: 12581320
[No Abstract] [Full Text] [Related]
6. Transplantation and the CD28/CTLA4/B7 pathway.
Alegre M; Fallarino F; Zhou P; Frauwirth K; Thistlethwaite J; Newell K; Gajewski T; Bluestone J
Transplant Proc; 2001; 33(1-2):209-11. PubMed ID: 11266782
[No Abstract] [Full Text] [Related]
7. Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells.
Wang XB; Zheng CY; Giscombe R; Lefvert AK
Scand J Immunol; 2001 Nov; 54(5):453-8. PubMed ID: 11696196
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection.
Nadeau K; Azuma H; Chandraker A; Sayegh MH; Tilney NL
Transplant Proc; 1997; 29(1-2):1038. PubMed ID: 9123187
[No Abstract] [Full Text] [Related]
9. Cytokine and cytotoxic molecule gene expression determined in peripheral blood mononuclear cells in the diagnosis of acute renal rejection.
Dugré FJ; Gaudreau S; Belles-Isles M; Houde I; Roy R
Transplantation; 2000 Oct; 70(7):1074-80. PubMed ID: 11045645
[TBL] [Abstract][Full Text] [Related]
10. Immune monitoring for rejection of kidney transplants.
Soulillou JP
N Engl J Med; 2001 Mar; 344(13):1006-7. PubMed ID: 11274628
[No Abstract] [Full Text] [Related]
11. Reduced CTLA-4 protein and messenger RNA expression in umbilical cord blood T lymphocytes.
Miller RE; Fayen JD; Mohammad SF; Stein K; Kadereit S; Woods KD; Sramkoski RM; Jacobberger JW; Templeton D; Shurin SB; Laughlin MJ
Exp Hematol; 2002 Jul; 30(7):738-44. PubMed ID: 12135671
[TBL] [Abstract][Full Text] [Related]
12. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
Miura Y; Thoburn CJ; Bright EC; Hess AD
Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
[TBL] [Abstract][Full Text] [Related]
13. Addition of an IL-15 mutant/FCgamma2A antagonist protein protects islet allografts from rejection overriding costimulation blockade.
Ferrari-Lacraz S; Zheng XX; Kim YS; Maslinski W; Strom TB
Transplant Proc; 2002 May; 34(3):745-7. PubMed ID: 12034169
[No Abstract] [Full Text] [Related]
14. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
[No Abstract] [Full Text] [Related]
16. Blocking T-cell costimulation to prevent transplant rejection.
Zheng XG; Turka LA
Transplant Proc; 1998 Aug; 30(5):2146-9. PubMed ID: 9723421
[No Abstract] [Full Text] [Related]
17. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection.
Han D; Xu X; Baidal D; Leith J; Ricordi C; Alejandro R; Kenyon NS
Diabetes; 2004 Sep; 53(9):2281-90. PubMed ID: 15331537
[TBL] [Abstract][Full Text] [Related]
19. T-cell infiltration in polymyositis is characterized by coexpression of cytotoxic and T-cell-activating cytokine transcripts.
Andreetta F; Bernasconi P; Torchiana E; Baggi F; Cornelio F; Mantegazza R
Ann N Y Acad Sci; 1995 Jul; 756():418-20. PubMed ID: 7645862
[No Abstract] [Full Text] [Related]
20. Negative regulation of T cell activation.
Saito T
Curr Opin Immunol; 1998 Jun; 10(3):313-21. PubMed ID: 9638368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
